Predicting Response to Lithium in Mood Disorders: Role of Genetic Polymorphisms

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.3, Iss.1, 2003-01, pp. : 17-30

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lithium long-term treatment in mood disorders: clinical and genetic predictors

By Serretti Alessandro

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 117-129

Future Medicine

Access to resources Recommend Favorite

Combining genetic and genomic approaches to study mood disorders

By Sibille E. Hen R.

European Neuropsychopharmacology, Vol. 11, Iss. 6, 2001-12 ,pp. : 413-421

Elsevier

Access to resources Recommend Favorite

Role of Estrogen in the Aetiology and Treatment of Mood Disorders

By Halbreich U. Kahn L.S.

CNS Drugs, Vol. 15, Iss. 10, 2001-01 ,pp. : 797-817

Adis International

Access to resources Recommend Favorite

Role of melatonin in mood disorders and the antidepressant effects of agomelatine

By Srinivasan Venkataramanujam De Berardis Domenico Shillcutt Samuel D Brzezinski Amnon

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1503-1522

Informa Healthcare

Access to resources Recommend Favorite

Predicting Treatment Response in Pediatric Anxiety Disorders

Child and Adolescent Psychopharmacology News, Vol. 19, Iss. 5, 2014-10 ,pp. : 7-9

Guilford Publications Inc

Access to resources Recommend Favorite